TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 101 filers reported holding TANGO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $631,618 | +265.6% | 56,094 | +28.3% | 0.00% | +100.0% |
| Q1 2023 | $172,757 | -51.0% | 43,736 | -10.1% | 0.00% | 0.0% |
| Q4 2022 | $352,669 | +153.7% | 48,644 | +26.8% | 0.00% | – |
| Q3 2022 | $139,000 | -23.2% | 38,362 | -4.1% | 0.00% | – |
| Q2 2022 | $181,000 | -26.7% | 40,003 | +22.7% | 0.00% | -100.0% |
| Q1 2022 | $247,000 | – | 32,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $211,842,000 | 60.92% |
| Cormorant Asset Management, LP | 4,899,185 | $53,149,000 | 3.16% |
| Boxer Capital, LLC | 6,871,642 | $75,176,000 | 2.92% |
| Casdin Capital, LLC | 5,487,910 | $60,038,000 | 1.69% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $21,024,000 | 1.67% |
| Samsara BioCapital, LLC | 630,000 | $6,892,000 | 1.34% |
| TANG CAPITAL MANAGEMENT LLC | 468,750 | $5,128,000 | 1.03% |
| HARVARD MANAGEMENT CO INC | 708,385 | $7,750,000 | 0.73% |
| HHLR ADVISORS, LTD. | 3,873,982 | $42,381,000 | 0.66% |
| Southpoint Capital Advisors LP | 3,000,000 | $32,820,000 | 0.63% |